Comparison
Compare two compounds, side by side.
Pick any two entries from the catalog and line up the fields that matter most before opening a full profile.
Primary use
Semaglutide is used or studied for weight loss; glycemic control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Tirzepatide is used or studied for significant weight loss; glucose control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Outcome tags
Fat LossMetabolic HealthAppetite Control
Fat LossMetabolic HealthAppetite Control
Benefits
Weight lossGlycemic control
Significant weight lossGlucose control
Side effects
NauseaGI upset
NauseaVomiting
Type
Peptide
Peptide
Format
Single compound
Single compound
Components
Not listed
Not listed
Evidence level
High
High
Regulatory status
FDA approved, prescription required
FDA approved, prescription required
Prescription required
Yes
Yes
Vendor protocol
Not listed
Not listed
Clinical protocol
Not listed
Not listed
Administration
InjectableIntravenous
Subcutaneous
Mechanism
Glp1 Receptor Agonist
Glp1 Receptor AgonistIncretin Pathway